BioprintingMedical

Celprogen 3D bioprints brain organelle for neurological disease research

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Stem cell research firm Celprogen Inc. has been working on something quite exciting for some time now, which has remained largely under the radar until very recently. The California-based company announced it has successfully 3D printed a human brain organelle using brain stem cells. The bioprinted brain could have applications in studying neurological diseases.

More than just announcing the bioprinted brain organelle, Celprogen has also used the brain to study the “role of Microglia activation and deactivation in neurological diseases.” Through this research and experimentation, the company says it has identified and characterized 11 lead compounds that could be potential drug candidates for diseases such as Alzheimer’s, Parkinson’s and Glioblastoma.

Celprogen bioprinted brain

The 3D printed brain was formed using a special bio matrix gel material (CEP707) which contains human brain stem cells, brain extracellular matrix and media. According to Celprogen, the 3D printed brain organelle is “routinely used” for internal toxicology and drug discovery program research, as well as for studying different types of brain cancer.

The 3D printed brain model pictured is reportedly developed specifically for testing how drugs transverse the blood brain barrier. Celprogen says it will present its research on the 3D bioprinted human brain at the upcoming Annual Neuroscience meeting in San Diego.

In addition to the 3D printed human brain organelle, Celprogen has a number of other bioprinting initiatives in the works. In 2016, for instance, the company introduced a 3D bioprinted human pancreas, which it is currently validating along with a 3D bioprinted heart, liver and hair follicle systems. All of the company’s bioprinting efforts are focused on toxicology and drug discovery research rather than implantation.

Research 2021
Ceramic AM Market Opportunities and Trends

This market study from 3dpbm Research provides an in-depth analysis and forecast of the ceramic additive ma...

Tess Boissonneault

Tess Boissonneault is a Montreal-based content writer and editor with five years of experience covering the additive manufacturing world. She has a particular interest in amplifying the voices of women working within the industry and is an avid follower of the ever-evolving AM sector. Tess holds a master's degree in Media Studies from the University of Amsterdam.

Related Articles

Back to top button

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Accept all Services

STAY AHEAD

OF THE CURVE

Join industry leaders and receive the latest insights on what really matters in AM!

This information will never be shared with 3rd parties

I’ve read and accept the privacy policy.*

WELCOME ON BOARD!